Investing Profile
Kevin Bitterman
Your Intro Paths to Kevin Bitterman
Signal uses Gmail to reveal intro paths. Email content is never read.
Sign in with Google →Find Kevin Bitterman on
cbCurrent Investing Position
Atlas Venture Partner
Investment Range
$10.0M - $50.0M
Sweet Spot
$25.0M
Investments On Record
29
Kevin Bitterman is on these Sector & Stage Rankings
Kevin Bitterman's Investments On Record (12)
Company | StageDateRound Size | Total Raised |
---|---|---|
Curie Therapeutics | Series ADec 2021$75M | $75M |
Remix Therapeutics | Series ADec 2020$65M | $65M |
Akero Therapeutics | Series AJun 2018$65M | $65M |
Neuronetics | Series GJun 2017$15M Series FApr 2015$34M Series EMay 2011$30M | $110M |
Visterra | Series CJun 2016$23M Series BOct 2014$30M Series ADec 2013$8.1M Series ANov 2012$26M Seed RoundMay 2009$3.3M | $91M |
Kala Pharmaceuticals | Series CApr 2016$68M Series BApr 2014$23M Series AFeb 2013$12M Private Equity RoundMar 2012$7.2M | $110M |
Pulmatrix | Post-IPO EquityJun 2015$10M Series BAug 2011$14M Series BNov 2009$30M | $54M |
Arsenal Medical | Venture RoundJun 2015$16M Venture RoundMay 2010$10M | $26M |
Investors who invest with Kevin Bitterman